Research has indicated that mice colonized with fecal microbiota from melanoma patients who achieved a complete response to PD-1 antibody therapy develop significantly smaller MC38 tumors when treated with anti-PD-L1 monotherapy than mice colonized with fecal microbiota from nonresponding patients (59). Here, CD274 is linked to melanoma.